Aspen Pharmacare Holdings Ltd - ADR
APNHY
Market Cap$3B
Close$
$9.76
43.2% upside
Current Fair Value
43.2% upsideUndervalued by 43.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.00 Billion |
|---|---|
| Enterprise Value | $32.11 Billion |
| Dividend Yield | $0.2 (2.87545054064878%) |
| Earnings per Share | $9.91 |
| Beta | 0.44 |
| Outstanding Shares | 444,124,655 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 12.38 |
|---|---|
| PEG | -68.15 |
| Price to Sales | 0.07 |
| Price to Book Ratio | 0.04 |
| Enterprise Value to Revenue | 0.72 |
| Enterprise Value to EBIT | 3.61 |
| Enterprise Value to Net Income | 7 |
| Total Debt to Enterprise | 1.29 |
| Debt to Equity | 0.49 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Aspen Pharmacare Holdings Ltd
CEO: Stephen Saad